Baxter Intl

BAX NYSE
86.97
+1.19
+1.39%
After Hours: 86.97 0 0.00% 17:56 08/16 EDT
Open
86.31
Prev Close
85.78
High
87.41
Low
86.10
Volume
1.58M
Avg Vol (3M)
2.28M
52 Week High
88.28
52 Week Low
61.05
% Turnover
0.31%
Market Cap
44.40B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Baxter Intl BAX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Baxter International Inc., through its subsidiaries, provides renal and hospital products. The Company operates through two segments: Hospital Products and Renal. Its Hospital Products business manufactures sterile intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics and biosurgery products. The Renal business offers a portfolio to meet the needs of patients with end-stage renal disease, or irreversible kidney disease and acute kidney injuries, including technologies and therapies for peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapy (CRRT) and additional dialysis services. Its products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices and by patients at home under physician supervision.
MORE >

Recently

Name
Price
%Change